Earnings Summary

Century Therapeutics Inc’s revenue fell -48.56% since last year same period to $0.27Mn in the Q4 2023. On a quarterly growth basis, Century Therapeutics Inc has generated 81.08% jump in its revenue since last 3-months.

Century Therapeutics Inc’s net profit fell -24.35% since last year same period to $-39.4Mn in the Q4 2023. On a quarterly growth basis, Century Therapeutics Inc has generated -20.41% fall in its net profits since last 3-months.

Century Therapeutics Inc’s net profit margin fell -141.75% since last year same period to -14700.75% in the Q4 2023. On a quarterly growth basis, Century Therapeutics Inc has generated 33.51% jump in its net profit margins since last 3-months.

Century Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.62 - a -13.18% fall from last quarter’s estimates.

Century Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.62.

Century Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Century Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.